Showing results (11-20 of 86) with videos related to
Sort By:
Pageof 9
Pharmaceutical Statistics|November 27, 2015
Do single-arm trials have a role in drug development plans incorporating randomised trials?Michael J Grayling, Adrian P ManderJournal of Biopharmaceutical Statistics|June 2, 2012
Minimizing the maximum expected sample size in two-stage Phase II clinical trials with continuous outcomesJames M S Wason, Adrian P ManderStatistical Methods in Medical Research|December 20, 2011
The choice of test in phase II cancer trials assessing continuous tumour shrinkage when complete responses are expectedJames M S Wason, Adrian P ManderPharmaceutical Statistics|July 29, 2024
Efficient Study Design and Analysis of Longitudinal Dose-Response Data Using Fractional PolynomialsBenjamin F Hartley, Dave Lunn, Adrian P ManderJournal of Biopharmaceutical Statistics|January 25, 2022
A stochastically curtailed single-arm phase II trial design for binary outcomesMartin Law, Michael J Grayling, Adrian P ManderPharmaceutical Statistics|August 30, 2020
A stochastically curtailed two-arm randomised phase II trial design for binary outcomesMartin Law, Michael J Grayling, Adrian P ManderTrials|December 4, 2019
Sample size re-estimation in crossover trials: application to the AIM HY-INFORM studyJulie Wych, Michael J Grayling, Adrian P ManderTrials|September 19, 2014
Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?James M S Wason, Lynne Stecher, Adrian P ManderPlos One|July 13, 2016
AplusB: A Web Application for Investigating A + B Designs for Phase I Cancer Clinical TrialsGraham M Wheeler, Michael J Sweeting, Adrian P ManderClinical Trials (London, England)|June 28, 2017
Group sequential designs for stepped-wedge cluster randomised trialsMichael J Grayling, James Ms Wason, Adrian P ManderPageof 9